Egypt launches program to improve heart and kidney disease care

A pharmaceutical company, in collaboration with the Ministry of Health and Population, the World Health Organization, and the Heart Health Program in Africa, launched a program in Cairo on Thursday to enhance heart and kidney disease care. Dr. Khaled Abdel Ghaffar, Minister of Health and Population, stated that approximately 29 percent of Egyptians suffer from hypertension, 14 percent from kidney disease, and 15 percent from diabetes. The Minister noted that awareness campaigns are underway to reach citizens in various locations. He also highlighted Egypt's international recognition for its health initiatives, achieved through partnerships with pharmaceutical companies and the World Health Organization. The program focuses on increasing community awareness, supporting early detection, developing medical personnel, and standardizing operational mechanisms among healthcare stakeholders. This initiative aims to improve the quality of healthcare services and treatment outcomes for Egyptian citizens. The launch event was attended by Dr. Khaled Abdel Ghaffar, Dr. Mohamed Hassani, Assistant Minister of Health and Population for Public Health Projects and Initiatives, and Dr. Nima Saeed Abid, WHO Representative in Egypt, among other officials.